Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,otherCurrentAssets,shortTermInvestments,otherCurrentLiab,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,currency,market,shortName,exchange,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,exchangeDataDelayedBy,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Apr 29, 2021) 4","Short Ratio (Apr 29, 2021) 4","Short % of Float (Apr 29, 2021) 4","Short % of Shares Outstanding (Apr 29, 2021) 4","Shares Short (prior month Mar 30, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,ICCC,27684905.0,7735990,1031064,,-441303,,-441303,945749,1602188,-374625,-374625,,,,,,0,4107146,4481771,2504958,-66678,,-441303,-441303,90744.0,31414027.0,11750256.0,27871206.0,39621462.0,729901.0,-4101705.0,95557.0,-171017.0,23386.0,6806650.0,2098265.0,767517.0,27601938.0,11809837.0,2390205.0,8543825.0,2122450.0,1228361.0,,,,996000,-41653,656684,-190377,-176425,-165989,11680,-143287,-623546,619471,-29936,-593404,2272,27308,-349316,9711572.0,en-US,US,EQUITY,True,Delayed Quote,8.65,1630526402,-0.5100002,8.795,9.07,8.16,51128,3.916,9.459429,-0.80942917,-0.0855685,9.841087,-1.1910877,-0.121032126,66916312,-78.63636,2.2088866,15,America/New_York,EDT,False,False,USD,us_market,ImmuCell Corporation,NCM,PRE,2,-5.567688,8.16 - 9.07,9.16,0.0,0.0,12,11,finmb_29789,NasdaqCM,ImmuCell Corporation,USD,14254,15971,3.6399994,0.72654676,5.01 - 13.2,-4.55,-0.344697,5.01,13.2,1620995400,1620995400,0,1620995400,-0.142,-0.11,-14400000,,,,13.2,5.01,9.46,9.84,14.25k,15.97k,7.74M,,5.17M,28.62%,10.19%,12.62k,0.93,0.19%,0.16%,6.67k,,,,,,0.00%,,,1:100,"Jul 24, 1990","Dec 30, 2020","Mar 30, 2021",-9.23%,-13.43%,-3.06%,-4.72%,14.54M,2.02,-16.40%,6.86M,455k,-1.34M,-0.14,,6.81M,0.94,10.52M,37.75,5.63,3.92,-165.42k,-3M,Value,04103,Healthcare,56,"ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.",Portland,207 878 2770,ME,1609372800,United States,http://immucell.com,86400,56 Evergreen Drive,Biotechnology
t-1,ICCC,28075123.0,7735990,1170429,,193326,,188830,1084971,1621036,-634364,-634364,,,,,,4496,3743346,4377710,2122310,827690,,188830,188830,95520.0,31372093.0,12083394.0,28266200.0,40349594.0,729901.0,-3660402.0,95557.0,-175392.0,26173.0,6949937.0,2211076.0,760337.0,27975336.0,12157008.0,1864422.0,8737149.0,2092514.0,602347.0,800.0,996495.0,,996000,377662,756321,730579,717241,71031,9,1629810,156248,613562,-1697,-254256,-13347,-840531,-284679,9945932.0,en-US,US,EQUITY,True,Delayed Quote,8.65,1630526402,-0.5100002,8.795,9.07,8.16,51128,3.916,9.459429,-0.80942917,-0.0855685,9.841087,-1.1910877,-0.121032126,66916312,-78.63636,2.2088866,15,America/New_York,EDT,False,False,USD,us_market,ImmuCell Corporation,NCM,PRE,2,-5.567688,8.16 - 9.07,9.16,0.0,0.0,12,11,finmb_29789,NasdaqCM,ImmuCell Corporation,USD,14254,15971,3.6399994,0.72654676,5.01 - 13.2,-4.55,-0.344697,5.01,13.2,1620995400,1620995400,0,1620995400,-0.142,-0.11,-14400000,,,,13.2,5.01,9.46,9.84,14.25k,15.97k,7.74M,,5.17M,28.62%,10.19%,12.62k,0.93,0.19%,0.16%,6.67k,,,,,,0.00%,,,1:100,"Jul 24, 1990","Dec 30, 2020","Mar 30, 2021",-9.23%,-13.43%,-3.06%,-4.72%,14.54M,2.02,-16.40%,6.86M,455k,-1.34M,-0.14,,6.81M,0.94,10.52M,37.75,5.63,3.92,-165.42k,-3M,Value,04103,Healthcare,56,"ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.",Portland,207 878 2770,ME,1609372800,United States,http://immucell.com,86400,56 Evergreen Drive,Biotechnology
t-2,ICCC,27824808.0,7735990,1123144,,-322888,,-322888,850905,1722451,-251598,-251598,,-75941.0,,,,0,3722517,3974115,2000066,-71290,,-322888,-322888,100296.0,31328328.0,11966547.0,28020661.0,39987208.0,729901.0,-3849232.0,95557.0,-188336.0,1427232.0,3918157.0,1801848.0,711906.0,28426906.0,9937217.0,1613598.0,9004402.0,2090817.0,444252.0,800.0,1992538.0,19925.0,996000,-113730,-1473124,-143175,-143175,-143315,9,-2283626,-667327,600787,-197413,-559698,-13347,67366,-1473124,8135369.0,en-US,US,EQUITY,True,Delayed Quote,8.65,1630526402,-0.5100002,8.795,9.07,8.16,51128,3.916,9.459429,-0.80942917,-0.0855685,9.841087,-1.1910877,-0.121032126,66916312,-78.63636,2.2088866,15,America/New_York,EDT,False,False,USD,us_market,ImmuCell Corporation,NCM,PRE,2,-5.567688,8.16 - 9.07,9.16,0.0,0.0,12,11,finmb_29789,NasdaqCM,ImmuCell Corporation,USD,14254,15971,3.6399994,0.72654676,5.01 - 13.2,-4.55,-0.344697,5.01,13.2,1620995400,1620995400,0,1620995400,-0.142,-0.11,-14400000,,,,13.2,5.01,9.46,9.84,14.25k,15.97k,7.74M,,5.17M,28.62%,10.19%,12.62k,0.93,0.19%,0.16%,6.67k,,,,,,0.00%,,,1:100,"Jul 24, 1990","Dec 30, 2020","Mar 30, 2021",-9.23%,-13.43%,-3.06%,-4.72%,14.54M,2.02,-16.40%,6.86M,455k,-1.34M,-0.14,,6.81M,0.94,10.52M,37.75,5.63,3.92,-165.42k,-3M,Value,04103,Healthcare,56,"ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.",Portland,207 878 2770,ME,1609372800,United States,http://immucell.com,86400,56 Evergreen Drive,Biotechnology
t-3,ICCC,28080523.0,7735990,1086627,,-765793,,-765793,887878,1283236,-691269,-691269,,-77049.0,,,,0,2965953,3657222,1682717,-74524,,-765793,-765793,105072.0,31265931.0,12379430.0,28281152.0,40660582.0,729901.0,-3526344.0,95557.0,-188336.0,1424794.0,6202663.0,2376019.0,1044967.0,27712304.0,11322855.0,999641.0,8812950.0,1893404.0,532305.0,800.0,1992098.0,150358.0,-1504000,274443,-2566589,1295806,1295806,227400,9,-301579,969204,573034,-295446,892936,-13347,61064,-1062589,8946836.0,en-US,US,EQUITY,True,Delayed Quote,8.65,1630526402,-0.5100002,8.795,9.07,8.16,51128,3.916,9.459429,-0.80942917,-0.0855685,9.841087,-1.1910877,-0.121032126,66916312,-78.63636,2.2088866,15,America/New_York,EDT,False,False,USD,us_market,ImmuCell Corporation,NCM,PRE,2,-5.567688,8.16 - 9.07,9.16,0.0,0.0,12,11,finmb_29789,NasdaqCM,ImmuCell Corporation,USD,14254,15971,3.6399994,0.72654676,5.01 - 13.2,-4.55,-0.344697,5.01,13.2,1620995400,1620995400,0,1620995400,-0.142,-0.11,-14400000,,,,13.2,5.01,9.46,9.84,14.25k,15.97k,7.74M,,5.17M,28.62%,10.19%,12.62k,0.93,0.19%,0.16%,6.67k,,,,,,0.00%,,,1:100,"Jul 24, 1990","Dec 30, 2020","Mar 30, 2021",-9.23%,-13.43%,-3.06%,-4.72%,14.54M,2.02,-16.40%,6.86M,455k,-1.34M,-0.14,,6.81M,0.94,10.52M,37.75,5.63,3.92,-165.42k,-3M,Value,04103,Healthcare,56,"ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.",Portland,207 878 2770,ME,1609372800,United States,http://immucell.com,86400,56 Evergreen Drive,Biotechnology
